51
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Reduction in costs of inpatient stay associated with clozapine treatment: A retrospective study

, MSc BSc, , MSc BSc, , MB BS MPH MFPHM, , BA MB FFCM FFPHM, , MD FRCPsych FRCP(I) DPM & , BA MB BCh BAO MRC Psych FRCP(I)
Pages 69-79 | Accepted 03 Nov 1997, Published online: 02 Dec 2008

References

  • Clozapine Study Group. The safety and efficacy of clozapine in severe treatment -resistant schizophrenic patients in the UK. British Journal of Psychiatry 1993; 163: 150–154.
  • Kane J, Honigfeld G, Singer J et al. Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorpromazine. Archives of General Psychiatry 1988; 45: 789–796.
  • Meltzer HY. Dimensions of outcome with clozapine. British Journal of Psychiatry 1992; 160 (suppl. 17) 46–53.
  • King DJ and Mills PJ. Clozapine: the holywell experience with the first 24 patients. Irish Journal of Psychological Medicine, Feb 1993; 10(1): 30–34.
  • McKenna PJ, Bailey PE. The strange story of clozapine. British Journal of Psychiatry 1993; 162: 32 – 37.
  • Meltzer H, Cola P, Way L et al. Cost effectiveness of clozapine in antipsychotic-resistant schizophrenia. American Journal of Psychiatry 1993; 150: 11.
  • Revicki DA, Luce BR, Weschler JM et al. Cost effectiveness of clozapine for treatment-resistant schizophrenic patients. Hospital and Community Psychiatry 1990; 41(8): 850–854.
  • Chui E, Burrows G, Stevenson J. Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness. Australian and New Zealand Journal of Psychiatry 1976; 10: 343–347.
  • Borison RL, Diamond BI, Sinha D et al. Clozapine withdrawal rebound psychosis. Psychopharmacology Bulletin 1988; 24: 260–263.
  • Claghorn J, Honigfeld G, Abuzzahab FS et al. The risks and benefits of clozapine versus chlorpromazine. Journal of Clinical Psychopharmacology 1987; 7: 377–84.
  • Conley RR, Schulz SC, Baker RW et al. Clozapine efficacy in schizophrenic nonresponders. Psychopharmacology Bulletin 1988; 24: 269–74.
  • Herrera JM, Costa J, Sramek J et al. Clozapine in refractory schizophrenia. Schizophrenia Research 1988; 1: 305–6.
  • Reid WH, Mason M, Toprac M. Savings in hospital bed-days related to treatment with clozapine. Hospital and Community Psychiatry 1994; 45: 261–264.
  • Shepherd M, Watt D, Falloon IRH et al. The natural history of schizophrenia: a five year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine Monograph Supplement 1989; 15: 1–46.
  • Davies LM, Drummond MF. Assessment of costs and benefits of drug therapy for treatment resistant schizophrenia in the united kingdom. British Journal of Psychiatry 1993; 162: 38–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.